|
News Feeds from
"Medical News Today"
Immune System / Vaccines News
The news and information from
Medical News Today are widely recognized as being timely,
accurate and unbiased - with no affiliations or connections to
any other organizations (media or otherwise).
Here
MedRat®
BioArchives
presents
the latest news feeds from Medical News Today encompassing
Immune System / Vaccines News.
Immune System / Vaccines News From Medical News Today
Latest Health News and Medical News posted throughout the day, every day.
Antigenics Presents Positive, Top Line Data From Phase I Herpes Clinical Trial
29 Jul 2010 at 1:00am
Antigenics (NASDAQ: AGEN) announced positive results with AG-707, an investigational therapeutic vaccine being developed to treat herpes simplex virus-2 (HSV-2), the virus that causes genital herpes, in infected patients. Developed by Antigenics, the vaccine triggers a cellular immune response, stimulating both CD4+ and CD8+ T cells...
Peer-Reviewed Journal Publishes Findings By Viral Genetics' Lead Scientist
29 Jul 2010 at 1:00am
Research co-authored by Viral Genetics, Inc., (Pink Sheets: VRAL) lead scientist Dr. M. Karen Newell has been published in the peer-reviewed Journal of Leukocyte Biology (JLB). Newell's article identifies a potential mechanism that promotes chronic inflammation, a characteristic of most autoimmune diseases. Viral Genetics has been pursing treatments for Lyme Disease and HIV/AIDS...
Opinions: Improving Malaria Control, Treatment; Faith Organizations In Fight ...
28 Jul 2010 at 6:00am
To Improve Malaria Control, Remove Taxes On Medicines In a Wall Street Journal opinion piece, Jakaya Mrisho Kikwete, president of the United Republic of Tanzania, and Yoweri Museveni, president of the Republic of Uganda, both of the African Leaders Malaria Alliance, write about ways to overcome barriers to malaria control and treatment...
FDA Grants Orphan Drug Status For Personalized Cancer Vaccine, BiovaxID(R), T...
28 Jul 2010 at 2:00am
Biovest International, Inc. (OTCQB: "BVTI) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to BiovaxID®, Biovest's personalized cancer vaccine, for a second lymphoma indication: mantle cell lymphoma. Mantle cell lymphoma is an aggressive and lethal B-cell blood cancer for which there is no current consensus standard-of-care...
Dynavax Completes Enrollment And First Immunizations In Universal Flu Vaccine...
28 Jul 2010 at 2:00am
Dynavax Technologies Corporation (NASDAQ: DVAX) reported completing enrollment and the first immunizations of 39 subjects enrolled in its Phase 1 study of the company's Universal Flu vaccine. Safety and immunogenicity data from this study are anticipated in the fourth quarter of this year...
Boston University Wins $1.6M NIH Grant To Target Protein-Protein Interactions
28 Jul 2010 at 1:00am
An interdisciplinary team of Boston University professors is launching a project to develop new ways to target protein-protein interactions with synthetic organic drugs. Financed by a four-year $1...
Canadian Researchers Testing Unique Vaccines For Prion Diseases And Common Ca...
27 Jul 2010 at 8:00am
Several Canadian researchers have come together to help control the relentless spread of a prion disease, chronic wasting disease (CWD) in deer and elk, through vaccines. At the same time they aim to generate safe and effective therapies for common cancers. This simultaneous research is possible thanks to a unique connection they have discovered between the two unrelated diseases...
News From The Journal Of Clinical Investigation: July 26, 2010
27 Jul 2010 at 6:00am
CARDIOVASCULAR DISEASE: Flushing out key limitations to a drug that protects against heart attack The drug niacin is used to modulate fat levels in the blood and thereby reduce the risk of a heart attack. However, noxious effects on the skin that have been termed 'flushing' limit its use in the clinic...
Researchers Uncover Biological Rationale For Why Intensive Lupus Treatment Works
27 Jul 2010 at 2:00am
Researchers at UT Southwestern Medical Center have uncovered the biological rationale for why large doses of corticosteroids given repeatedly over several weeks may help individuals with lupus, a chronic inflammatory disease that affects more than 1 million people in the U.S...
Legionnaire's Disease Bacteria Tap Into The Material Transport In Immune Cells
26 Jul 2010 at 2:00am
During a Legionella infection, the bacteria are engulfed by immune cells and bound by a membrane in the cell interior. Legionella protects itself against destruction by releasing proteins that reprogramme the human cell and exploit it for its own purposes. One of these proteins is DrrA...
Non-Human Sugar In Biotech Drugs Causes Inflamation
26 Jul 2010 at 2:00am
Researchers at the University of California, San Diego School of Medicine have discovered that a kind of sugar molecule common to chimpanzees, gorillas and other mammals but not found in humans provokes a strong immune response in some people, likely worsening conditions in which chronic inflammation is a major issue...
Decreasing Atherosclerosis Risk By Inhibiting Fatty Acids In Immune Cells
26 Jul 2010 at 1:00am
Scientists at Washington University School of Medicine in St. Louis have found a way to significantly reduce atherosclerosis in mice that does not involve lowering cholesterol levels or eliminating other obesity-related problems. They report their findings in the July 23 issue of the Journal of Biological Chemistry...
Extended Funding For Long-Standing Investigation Into Regulation Of Gastroint...
24 Jul 2010 at 2:00am
Marc E. Rothenberg, M.D., Ph.D., director of the Division of Allergy and Immunology at Cincinnati Children's, has received an NIH MERIT Award to extend funding of his long-standing investigation into "Regulation of Gastrointestinal Eosinophils." Dr...
Computational Model Of Colon Inflammation Singles Out Dangerous Immune Cells
24 Jul 2010 at 1:00am
Scientists at the Virginia Bioinformatics Institute (VBI) at Virginia Tech have constructed a mathematical and computational model of inflammatory bowel disease that allows researchers to simulate the cellular and molecular changes underlying chronic inflammation in humans...
MabVax Therapeutics Initiates Phase II Clinical Trial Of Vaccine To Prevent R...
23 Jul 2010 at 3:00am
MabVax Therapeutics Inc., a privately held clinical stage biotechnology company focused on the development of vaccine and antibody based therapies to address the unmet medical need of preventing recurrent cancer, announces that the first patients have been enrolled in a Phase II clinical trial aimed at assessing the efficacy and safety of its vaccine to prevent or delay the recurrence of sarcoma...
Presented by MedRat®
|
|
